Champions Oncology Q3 Adj $(0.16) Misses $(0.15) Estimate, Sales $12.02M Miss $13.48M Estimate
Champions Oncology Q3 Adj $(0.16) Misses $(0.15) Estimate, Sales $12.02M Miss $13.48M Estimate
Champions Oncology第三季度調整後美元（0.16）未達到預期（0.15）美元，銷售額爲1,202萬美元，低於1348萬美元的預期
Champions Oncology (NASDAQ:CSBR) reported quarterly losses of $(0.16) per share which missed the analyst consensus estimate of $(0.15) by 6.67 percent. This is unchanged from the same period last year. The company reported quarterly sales of $12.02 million which missed the analyst consensus estimate of $13.48 million by 10.84 percent. This is a 5.90 percent decrease over sales of $12.77 million the same period last year.
Champions Oncology（納斯達克股票代碼：CSBR）公佈的季度虧損爲每股0.16美元，比分析師普遍預期的0.15美元（0.15美元）低6.67％。這與去年同期相比沒有變化。該公司公佈的季度銷售額爲1,202萬美元，比分析師普遍預期的1,348萬美元低10.84％。這比去年同期的1,277萬美元的銷售額下降了5.90％。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的，不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。